Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.47 -1.99 (-2.64%)
As of: Oct 2, 2026 · 2:52 PM EDT

Tarsus Pharmaceuticals (TARS) Depreciation & Amortization (CF) (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) reported Depreciation & Amortization (CF) of $800,000 for Q2 2026, up 300.0% from $200,000 a year earlier and up 300.0% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Tarsus Pharmaceuticals' Depreciation & Amortization (CF) came in at $1.4 million, up 70.7% year-over-year; for FY2025, it was $900,000, up 28.6% from FY2024.

  • Depreciation & Amortization (CF) has a five-year compound annual growth rate of 56.5% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $700,000 in FY2024 (-5.9%), $744,000 in FY2023 (+128.9%), $325,000 in FY2022 (+4.2%) and $312,000 in FY2021 (+225.0%).
  • The Q2 2026 figure ranks as the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2019.
  • Year over year, Depreciation & Amortization (CF) gained in three of the last eight quarters, with growth averaging 47.9%.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q2 2026 (growth of 300.0%); the low point was Q2 2024 (a decline of 45.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $200,000 (Q1 2026), $200,000 (Q4 2025) and $200,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Tarsus Pharmaceuticals 3.40 Bn 2.35 Bn 161.80 Mn 800,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 800,000.00
Mar 31, 2026 200,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 200,000.00
Jun 30, 2025 200,000.00
Mar 31, 2025 220,000.00
Dec 31, 2024 200,000.00
Sep 30, 2024 200,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 200,000.00
Dec 31, 2023 244,000.00
Sep 30, 2023 200,000.00
Jun 30, 2023 182,000.00
Mar 31, 2023 104,000.00
Dec 31, 2022 98,000.00
Sep 30, 2022 94,000.00
Jun 30, 2022 92,000.00
Mar 31, 2022 41,000.00
Dec 31, 2021 40,000.00
Sep 30, 2021 83,000.00
API Access

Tarsus Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=TARS&period=max&api_key=YOUR_API_KEY